Federal grants to Epivax Inc
Epivax Inc in Providence, Rhode Island received $3.5 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Food and Drug Administration Research, with $2.0 million. In fiscal 2025 more was taken back from its awards than added, a net -$268,577.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.5 million
- Awards4
- Awarded in FY 2025-$268,577
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $1.1 million |
| FY 2022 | 1 | $2.0 million |
| FY 2023 | 2 | $599,847 |
| FY 2024 | 0 | $0 |
| FY 2025 | 0 | -$268,577 |
Programs that fund Epivax Inc
| Program | Awards | Amount |
|---|---|---|
| Food and Drug Administration Research | 1 | $2.0 million |
| Allergy and Infectious Diseases Research | 2 | $1.2 million |
| Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects | 1 | $299,930 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $3.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Ispri-hcp: cho protein impurity immunogenicity risk prediction for improving biosimilar product development and assessing product interchangeability - abstract the identification and removal of host cell proteins (HCP) from biologic products is a critical step in biosimilar drug development. While t | Food and Drug Administration Research | August 24, 2022 | $2.0 million |
| Structure-guided design of CD4 t cell memory-enhanced rha H7N9 influenza vaccine | Allergy and Infectious Diseases Research | July 26, 2021 | $854,892 |
| PA21259, sbir, phase i, improving t cell responses in vaccines: prediction and validation using existing databases, immunoinformatics and in vitro assays | Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects | August 23, 2023 | $299,930 |
| Validation and improvement of ispri-hcp: an innovative platform for immunogenicity risk assessment of process-related protein impurities - abstract the identification and removal of process-related protein impurities (PRPI) from biologic products is a critical step in drug development. Despite recen | Allergy and Infectious Diseases Research | July 27, 2023 | $299,917 |
Questions people ask
How much federal grant money does Epivax Inc get?
$3.5 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Epivax Inc the most?
The Department of Health and Human Services, with $3.5 million in 4 awards.
What is Epivax Inc's largest federal grant?
$2.0 million under Food and Drug Administration Research, with its first action in the period on August 24, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Epivax Inc?
Its largest are Food and Drug Administration Research, Allergy and Infectious Diseases Research and Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects.
Other grant recipients in Providence
- State of Rhode Island Department of Administration
- Rhode Island Dot
- RI Department of Elementary and Secondary Education
- Brown University
- State of Rhode Island Department of Health
- Rhode Island Infrastructure Bank
- Rhode Island Public Transit Authority
- State of Rhode Island Office of Energy Resources
Largest federal grant recipients in Rhode Island · Federal grants in Rhode Island